PATENT CLAIM ANALYSIS

Application Number: 16168503
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "133100"]

Abstract:
The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.

Claim (Index 7):
The antibody, or antigen-binding fragment thereof, of  claim 6 , wherein the Fab comprises a truncation in the upper hinge of the heavy chain constant region.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15336171', '14937778', '15274612', '13651289', '15895741']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7993087685417031
- 35 USC 102 Novelty (BERT): 0.5893647204008107
- Combined Prediction Score: 0.7783143637276138
- Mean Citation Score: 522.1880259999998
- Max Citation Score: 684.88605
- Similarity Product: 438.440140222156

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test